Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy [PDF]
Boaz Wong +6 more
openalex +1 more source
Syöpää sairastavien potilaiden elämänlaatu virushoitokokeilun aikana [PDF]
Opinnäytetyön tarkoituksena on kuvata syöpää sairastavien potilaiden kokemaa elämänlaatua ja sen muuttumista virushoitokokeilun aikana. Opinnäytetyön tavoitteena on pohtia virushoidon merkitystä potilaiden kokemaan elämänlaatuun ja tuottaa tietoa ...
Helander, Marjukka, Vesala, Tuulikki
core
This study reports a strategy to overcome immune escape of tumors during viro-immunotherapy due to tumor heterogeneity. We pursued a dual-targeting approach of epidermal growth factor receptor (EGFR) and cellular mesenchymal epithelial transition factor (
Martin A. Boos +8 more
doaj +1 more source
Markedly enhanced intratumoral spread and antitumor effect of oncolytic adenovirus expressing decorin [PDF]
With the aim of improving viral distribution and tumor penetration, we have engineered decorin expressing replication-incompetent (dl-LacZ-DCNG) and -competent (Ad-[DELTA]E1B-DCNG) adenoviruses.
A-Rum Yoon +7 more
core +1 more source
Oncolytic virotherapy as a personalized cancer vaccine [PDF]
Qi‐Xiang Li +2 more
openalex +1 more source
Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy [PDF]
Dana Haddad +8 more
openalex +1 more source
Current Development of Virotherapy in Breast Cancer: A Brief Review
Breast cancer is the cancer with the greatest incidence in the world by 2020. This cancer has a high mortality rate, has the capability of metastasizing, and causes damage to important organs of the human body.
Sasmana I. +4 more
doaj +1 more source
Growing Promise of Oncolytic Virotherapy: Opportunities and Pitfalls of NDV In Cancer Therapy [PDF]
Deepthi Balam
openalex +1 more source
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
A. Ribas +19 more
semanticscholar +1 more source

